All CD4+IFNγ-/- T cell recipients that received anti-IL-17A hardly lost weight upon R. typhi infection (Fig 9B, left), showed a very weak temporary clinical score peaking on day 12 post infection (Fig 9B, middle) and survived the infection (Fig 9B, right). Here, IL17A is linked to infection.